Hypoxia-induced COX-2 translocation:: In vivo and in vitro studies

被引：0
|
作者：
Barnett, JM [1 ]
Fowler, JA [1 ]
McCollum, GW [1 ]
Yang, R [1 ]
Penn, JS [1 ]
机构：
[1] Vanderbilt Univ, Sch Med, Nashville, TN 37212 USA
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2005年 / 46卷
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
4188
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Hypoxia-induced nuclear translocation of β-catenin in the healing process of frostbite
    Isozaki, Shotaro
    Tanaka, Hiroki
    Horioka, Kie
    Konishi, Hiroaki
    Kashima, Shin
    Takauji, Shuhei
    Fujiya, Mikihiro
    Druid, Henrik
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2022, 1868 (06):
  • [42] Mutant IκBα suppresses hypoxia-induced VEGF expression through downregulation of HIF-1α and COX-2 in human glioma cells
    Wu, JL
    Abe, T
    Kimba, Y
    Inoue, R
    Fujiki, M
    Kobayashi, H
    NEURO-ONCOLOGY, 2004, 6 (04) : 314 - 314
  • [43] Mutant IκBα suppresses hypoxia-induced VEGF expression through downregulation of HIF-1α and COX-2 in human glioma cells
    Kimba, Y
    Abe, T
    Wu, JL
    Inoue, R
    Fukiki, M
    Kohno, K
    Kobayashi, H
    ONCOLOGY RESEARCH, 2005, 15 (03) : 139 - 149
  • [44] Transcriptional regulation of cyclooxygenase-2 (COX-2) in hypoxia
    Cook-Johnson, Rebecca J.
    Peet, Dan
    Gamble, Jenny
    Cleland, Leslie
    James, Michael
    INFLAMMATION RESEARCH, 2005, 54 : S183 - S183
  • [45] Endotoxin induces proliferation of NSCLC in vitro and in vivo: role of COX-2 and EGFR activation
    Hattar, Katja
    Savai, Rajkumar
    Subtil, Florentine S. B.
    Wilhelm, Jochen
    Schmall, Anja
    Lang, Dagmar S.
    Goldmann, Torsten
    Eul, Bastian
    Dahlem, Gabriele
    Fink, Ludger
    Schermuly, Ralph-Theo
    Banat, Gamal-Andre
    Sibelius, Ulf
    Grimminger, Friedrich
    Vollmer, Ekkehard
    Seeger, Werner
    Grandel, Ulrich
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2013, 62 (02) : 309 - 320
  • [46] Endotoxin induces proliferation of NSCLC in vitro and in vivo: role of COX-2 and EGFR activation
    Katja Hattar
    Rajkumar Savai
    Florentine S. B. Subtil
    Jochen Wilhelm
    Anja Schmall
    Dagmar S. Lang
    Torsten Goldmann
    Bastian Eul
    Gabriele Dahlem
    Ludger Fink
    Ralph-Theo Schermuly
    Gamal-Andre Banat
    Ulf Sibelius
    Friedrich Grimminger
    Ekkehard Vollmer
    Werner Seeger
    Ulrich Grandel
    Cancer Immunology, Immunotherapy, 2013, 62 : 309 - 320
  • [47] COX-2 silencing enhances tamoxifen antitumor activity in breast cancer in vivo and in vitro
    Du, Ye
    Shi, Aiping
    Han, Bing
    Li, Sijie
    Wu, Di
    Jia, Hongyao
    Zheng, Chao
    Ren, Liqun
    Fan, Zhimin
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2014, 44 (04) : 1385 - 1393
  • [48] Characterization of Eltenac and novel COX-2 selective thiopheneacetic acid analogues in vitro and in vivo
    Klein, Thomas
    Dullweber, Frank
    Brehm, Christoph
    Prinz, Walter
    Baudler, Monika
    Figala, Volker
    Hermann, Michael
    BIOCHEMICAL PHARMACOLOGY, 2008, 76 (06) : 717 - 725
  • [49] Antitumor effect of the selective COX-2 inhibitor celecoxib on endometrial adenocarcinoma in vitro and in vivo
    Xiao, Yitao
    Teng, Yincheng
    Zhang, Rui
    Luo, Laimin
    ONCOLOGY LETTERS, 2012, 4 (06) : 1219 - 1224
  • [50] Celecoxib, a selective COX-2 inhibitor, reduces diabetes-induced retinal VEGF expression both in vitro and in vivo
    Ayalasomayajula, SP
    Kompella, UB
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2002, 43 : U298 - U298
12345